Lei Wang Selected Research

NGR peptide

11/2013	NIR-/pH-Responsive drug delivery of functionalized single-walled carbon nanotubes for potential application in cancer chemo-photothermal therapy.
1/2013	Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes.
1/2013	Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer.
1/2013	Single-walled carbon nanotubes mediated neovascularity targeted antitumor drug delivery system.
1/2011	Synergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Wang Research Topics

Disease

1440	Neoplasms (Cancer) 06/2024 - 04/2003
321	Inflammation (Inflammations) 05/2024 - 03/2004
263	Infections 05/2024 - 04/2003
219	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2003
165	Carcinogenesis 03/2024 - 06/2003
160	Breast Neoplasms (Breast Cancer) 04/2024 - 08/2003
157	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 07/2006
125	Fibrosis (Cirrhosis) 04/2024 - 01/2005
100	Glioma (Gliomas) 04/2024 - 03/2005
99	Hypoxia (Hypoxemia) 03/2024 - 11/2011
92	Lung Neoplasms (Lung Cancer) 01/2024 - 02/2006
91	Stomach Neoplasms (Stomach Cancer) 04/2024 - 10/2008
88	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 10/2006
87	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 03/2003
82	Ischemia 03/2024 - 04/2002
80	Reperfusion Injury 03/2024 - 09/2003
78	Wounds and Injuries (Trauma) 03/2024 - 05/2003
75	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 11/2009
74	Body Weight (Weight, Body) 05/2024 - 03/2005
72	Carcinoma (Carcinomatosis) 04/2024 - 03/2005
72	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 10/2004
67	Hypertension (High Blood Pressure) 05/2024 - 08/2006
66	Myocardial Infarction 05/2024 - 05/2006
61	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 05/2006
60	Necrosis 04/2024 - 03/2004
58	Colonic Neoplasms (Colon Cancer) 05/2024 - 10/2009
57	Pain (Aches) 02/2024 - 03/2005
55	Stroke (Strokes) 05/2024 - 02/2003
51	Adenocarcinoma 02/2024 - 10/2004
49	Hemorrhage 04/2024 - 06/2009
49	Type 2 Diabetes Mellitus (MODY) 03/2024 - 03/2012
49	Obesity 02/2024 - 05/2005
49	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2007
48	COVID-19 12/2023 - 01/2020
44	Atherosclerosis 04/2024 - 03/2004
44	Ischemic Stroke 03/2024 - 01/2013
42	Asthma (Bronchial Asthma) 04/2024 - 03/2004
42	Infarction (Infarctions) 03/2024 - 03/2002
41	Cognitive Dysfunction 04/2024 - 06/2013
41	Rectal Neoplasms (Rectal Cancer) 12/2023 - 03/2006
40	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 10/2004
40	Renal Cell Carcinoma (Grawitz Tumor) 02/2024 - 06/2011
40	Brain Ischemia (Cerebral Ischemia) 09/2023 - 02/2003
38	Melanoma (Melanoma, Malignant) 04/2024 - 09/2004
38	Heart Failure 01/2024 - 03/2004
36	Nasopharyngeal Carcinoma 12/2023 - 04/2004
35	Thrombosis (Thrombus) 04/2024 - 03/2011
34	Parkinson Disease (Parkinson's Disease) 12/2023 - 01/2005
33	Glioblastoma (Glioblastoma Multiforme) 06/2024 - 11/2007

Drug/Important Bio-Agent (IBA)

535	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2002
268	Biomarkers (Surrogate Marker)IBA 03/2024 - 02/2008
188	MicroRNAs (MicroRNA)IBA 05/2024 - 09/2009
139	Messenger RNA (mRNA)IBA 02/2024 - 03/2006
137	CytokinesIBA 05/2024 - 04/2005
115	Therapeutic UsesIBA 04/2024 - 06/2004
101	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 10/2007
96	Long Noncoding RNAIBA 03/2024 - 12/2014
92	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 09/2004
92	Peptides (Polypeptides)IBA 02/2024 - 03/2004
88	EnzymesIBA 03/2024 - 07/2002
86	RNA (Ribonucleic Acid)IBA 05/2024 - 09/2004
71	Small Interfering RNA (siRNA)IBA 02/2024 - 01/2006
68	AntioxidantsIBA 04/2024 - 09/2008
65	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 08/2012
59	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 11/2005
58	CateninsIBA 02/2024 - 02/2011
57	LipidsIBA 02/2024 - 05/2010
56	CollagenIBA 05/2024 - 04/2002
55	Interleukin-6 (Interleukin 6)IBA 05/2024 - 11/2006
55	LigandsIBA 04/2024 - 05/2005
52	AntigensIBA 04/2024 - 10/2005
52	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024 - 02/2003
50	Phosphotransferases (Kinase)IBA 04/2024 - 03/2009
43	Indicators and Reagents (Reagents)IBA 05/2024 - 05/2011
43	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 01/2012
43	VaccinesIBA 12/2023 - 06/2007
43	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 02/2003
41	LipopolysaccharidesIBA 05/2024 - 03/2006
41	Caspase 3 (Caspase-3)IBA 04/2024 - 01/2007
41	Oxygen (Dioxygen)IBA 03/2024 - 05/2003
38	Capsules (Microcapsules)IBA 03/2024 - 03/2005
37	Immune Checkpoint InhibitorsIBA 04/2024 - 09/2015
36	Circular RNAIBA 03/2024 - 01/2018
36	ErbB Receptors (EGF Receptor)IBA 01/2024 - 04/2002
35	InflammasomesIBA 04/2024 - 05/2015
34	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2024 - 06/2004
34	AntibodiesIBA 03/2024 - 09/2004
34	Insulin (Novolin)FDA Link 10/2023 - 12/2010
34	Transcription Factors (Transcription Factor)IBA 08/2023 - 09/2007

Therapy/Procedure

619	Therapeutics 05/2024 - 02/2003
223	Drug Therapy (Chemotherapy) 04/2024 - 02/2004
109	Immunotherapy 06/2024 - 01/2011
94	Radiotherapy 03/2024 - 09/2006
59	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2024 - 01/2005
46	Transplantation 01/2024 - 07/2002
42	Precision Medicine 03/2024 - 07/2012
38	Aftercare (After-Treatment) 04/2024 - 02/2005
38	Neoadjuvant Therapy 01/2024 - 10/2012
36	Stents 04/2024 - 05/2006
36	Lasers (Laser) 01/2024 - 02/2003